Diagnostics & Research

Week ending 29 May 2026 · Index 426.80 · Weekly return -1.85%. Constituents are ranked by weekly return.

Sector Healthcare

Universe all active equity exchanges for the country

Price basis Adjusted weekly close

Index chart

Index Value Trend Line Fair Value Activity Lines

For the week ending 29 May 2026, Diagnostics & Research declined 1.85% with 4 advancing, 7 declining, and 2 unchanged constituents.

Ticker Company Exchange Open High Low Close Return

2325 Yunkang Group Limited HKG 0.70 0.80 0.70 0.78 9.86%

8037 China Biotech Services Holdings Limited HKG 0.56 0.60 0.48 0.60 7.14%

6667 Mega Genomics Limited HKG 7.01 7.06 7.01 7.06 1.88%

2359 WuXi AppTec Co., Ltd. HKG 128.00 132.50 123.30 130.30 0.23%

0928 King International Investment Limited HKG 0.08 0.08 0.07 0.08 0.00%

8247 Biosino Bio-Technology and Science Incorporation HKG 3.00 3.00 2.84 3.00 0.00%

8225 China Health Group Inc. HKG 0.12 0.12 0.12 0.12 -0.80%

3347 Hangzhou Tigermed Consulting Co., Ltd HKG 32.04 32.04 29.64 30.94 -3.43%

2268 WuXi XDC Cayman Inc. HKG 56.60 58.85 51.90 54.90 -4.19%

9960 Kindstar Globalgene Technology, Inc. HKG 1.10 1.10 1.03 1.05 -4.55%

9860 Adicon Holdings Limited HKG 4.23 4.61 4.09 4.30 -6.93%

6127 Joinn Laboratories(China)Co.,Ltd. HKG 19.94 19.94 17.46 17.99 -9.42%

2427 Guanze Medical Information Industry (Holding) Co., Ltd. HKG 5.04 5.64 3.55 4.34 -13.89%